Provided by Tiger Trade Technology Pte. Ltd.

SH PHARMA

11.110
+0.1000.91%
Volume:983.40K
Turnover:10.90M
Market Cap:41.20B
PE:6.12
High:11.190
Open:11.190
Low:10.990
Close:11.010
52wk High:12.170
52wk Low:10.474
Shares:3.71B
HK Float Shares:919.07M
Volume Ratio:0.53
T/O Rate:0.11%
Dividend:0.53
Dividend Rate:4.78%
EPS(LYR):1.817
ROE:6.96%
ROA:2.34%
PB:0.45
PE(LYR):6.12
PS:0.12

Loading ...

Shanghai Pharmaceuticals to Dispose of Pharmaceutical Retail Subsidiary Through Public Listing

MT Newswires Live
·
Aug 25

SH Pharma Moves to Divest 51% Stake in Subsidiary Pharmacy via Public Listing

Stock News
·
Aug 24

Earning Preview: SH PHARMA Q2 revenue is expected to increase, institutional views are to be confirmed

Earnings Agent
·
Aug 20

Military Procurement Sanctions Mount Against Shanghai Pharma, Raising Governance Concerns

Deep News
·
Aug 18

SH PHARMA Sets 27 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express
·
Aug 17

Shanghai Pharmaceuticals' Unit Received Registration Certificate for Omeprazole, Sodium Bicarbonate for Oral Suspension

MT Newswires Live
·
Aug 04

Shanghai Pharmaceuticals Receives Production Approval for Omeprazole-Sodium Bicarbonate Suspension

Stock News
·
Aug 03

Shanghai Pharmaceuticals Gains Approval for New Cholesterol Drug Production

Stock News
·
Jul 30

Shanghai Pharmaceuticals Unveils Three New Products with Canadian Regulatory Approvals

Stock News
·
Jul 30

Shanghai Pharmaceuticals Ends Clinical Trial on Salvianolic Acid A for Injection

MT Newswires Live
·
Jul 27

SH PHARMA (02607) Halts Clinical Trial and Further Development of Salvianolic Acid A for Injection

Stock News
·
Jul 24

Shanghai Pharma Executes Partnership Agreement for Shanghai Biomedical Phase II Fund

Bulletin Express
·
Jul 24

Shanghai Pharmaceuticals Unit Gets China Clinical Trial Approval for Dry Eye Drug

MT Newswires Live
·
Jul 21

Shanghai Pharma Subsidiary's Ophthalmic Formula Cleared for Clinical Trials

Stock News
·
Jul 20

Shanghai Pharmaceuticals Arm to Divest 41% Stake in Subsidiary Through Public Listing

MT Newswires Live
·
Jul 20

Shanghai Pharma to Commit 300 Million Yuan in Second Biopharma Fund

Stock News
·
Jul 17

SH PHARMA: No Share Capital Movement in June 2026; 3.71 Billion Total Authorised Shares and Public Float Fully Compliant

Bulletin Express
·
Jul 02

Shanghai Pharma Secures Production Approval for Vigabatrin Oral Solution Powder

Stock News
·
Jun 29

AH Share Premium and Deviation Rankings for June 26

Stock News
·
Jun 26

SH PHARMA to Distribute Final Dividend of HKD 4.0477 per 10 Shares on August 24

Stock News
·
Jun 25